The novel adenosine A2a receptor antagonist ST1535 potentiates the effects of a threshold dose of L-DOPA in MPTP treated common marmosets
about
Adenosine A(2A) Receptor Antagonists and Parkinson's DiseaseCaffeine and a selective adenosine A2A receptor antagonist induce sensitization and cross-sensitization behavior associated with increased striatal dopamine in mice.Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson's disease.Adenosine A(2A) receptors in Parkinson's disease treatment.Dual-target-directed drugs that block monoamine oxidase B and adenosine A(2A) receptors for Parkinson's diseaseNovel investigational adenosine A2A receptor antagonists for Parkinson's disease.Novel therapy in Parkinson's disease: adenosine A(2A) receptor antagonists.New pharmacological avenues for the treatment of L-DOPA-induced dyskinesias in Parkinson's disease: targeting glutamate and adenosine receptors.Adenosine A2A receptor antagonists in Parkinson's disease: progress in clinical trials from the newly approved istradefylline to drugs in early development and those already discontinued.History and perspectives of A2A adenosine receptor antagonists as potential therapeutic agents.Molecular docking studies of 1-(substituted phenyl)-3-(naphtha [1, 2-d] thiazol-2-yl) urea/thiourea derivatives with human adenosine A(2A) receptor.A Meta-Analysis of Adenosine A2A Receptor Antagonists on Levodopa-Induced Dyskinesia In Vivo.PBF509, an Adenosine A Receptor Antagonist With Efficacy in Rodent Models of Movement Disorders
P2860
Q29346492-893650F7-1D1F-498A-9394-61EBEBD5FBD1Q33745754-ACA3EF91-9717-48DA-8ACA-C72D404A5818Q35489240-4D99D84D-8500-4DD8-919D-35C1F2608038Q36973390-38B6111E-7FBA-424A-BD5A-54F07211C7C1Q37358676-107735DE-F519-4B20-8F94-BD38CBA304A7Q37627259-9199680F-2BCF-4DCE-BA2C-65BA9BF8176EQ37844573-2AD7ACF5-C1C8-4B18-82E8-0A63D5F6B44AQ37974709-DAE80C85-36E5-4B60-95E7-F0DDC2E5E26AQ38200930-AB397E64-D7D0-4F6D-80A9-8C6091DA4F76Q38395423-484A542B-386E-4A65-866D-C919EB909325Q41908900-EAB8C544-216A-4C53-8B1F-01A4304CF936Q49452726-E840CFD1-58DD-4D45-A4C8-F9FFDDC319A8Q58587583-4D657039-25A8-4D5D-B8E8-4D6D66C1835B
P2860
The novel adenosine A2a receptor antagonist ST1535 potentiates the effects of a threshold dose of L-DOPA in MPTP treated common marmosets
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The novel adenosine A2a recept ...... MPTP treated common marmosets
@ast
The novel adenosine A2a recept ...... MPTP treated common marmosets
@en
The novel adenosine A2a recept ...... MPTP treated common marmosets
@nl
type
label
The novel adenosine A2a recept ...... MPTP treated common marmosets
@ast
The novel adenosine A2a recept ...... MPTP treated common marmosets
@en
The novel adenosine A2a recept ...... MPTP treated common marmosets
@nl
prefLabel
The novel adenosine A2a recept ...... MPTP treated common marmosets
@ast
The novel adenosine A2a recept ...... MPTP treated common marmosets
@en
The novel adenosine A2a recept ...... MPTP treated common marmosets
@nl
P2093
P1476
The novel adenosine A2a recept ...... MPTP treated common marmosets
@en
P2093
Kim Stockwell
Lance A Smith
Louisa Johnson
Michael J Jackson
Paolo Carminati
Peter Jenner
Sarah Rose
P356
10.1016/J.EJPHAR.2006.07.017
P407
P577
2006-09-28T00:00:00Z